Dextromethorphan hydrobromide (DXM) has been widely used as a nonopioid antitussive drug and is a psychotropic drug since 2003 in our country. This study was performed to investigate the immunotoxicity of DXM by assay of splenocytes proliferation (SP)...
Dextromethorphan hydrobromide (DXM) has been widely used as a nonopioid antitussive drug and is a psychotropic drug since 2003 in our country. This study was performed to investigate the immunotoxicity of DXM by assay of splenocytes proliferation (SP) and induction of cytokine (IFN-γ, IL-4) in vitro. When mouse splenocytes were exposed to various concentration of DXM (0.001, 0.01, 0.1, 1, 10, 100μM) and cultured with T cell mitogen (Con A) or B cell mitogen (LPS), SP to Con A and LPS were significantly decreased at high concentration (100μM) when compared with controls. When splenocytes were cultured with DXM in the presence of Con A, levels of IFN-γ in culture supernatant were slightly decreased at low concentration, and significantly decreased at high concentration (100μM). DXM also suppressed IL-4 secretion significantly at 100μM, however, increased the production of IL-4 at lower concentration when compared with control group. This study provides the substantial evidence on DXM-induced alternation in cell-mediated and humoral immunity.